Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia

详细信息    查看全文

• 作者：Robert S. Rosenson ; Terry A. Jacobson ; David Preiss…
• 刊名：Cardiovascular Drugs and Therapy
• 出版年：2016
• 出版时间：June 2016
• 年：2016
• 卷：30
• 期：3
• 页码：305-313
• 全文大小：512 KB
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  
• 出版者：Springer Netherlands
• ISSN：1573-7241
• 卷排序：30

文摘

PurposeEvolocumab significantly reduces low-density lipoprotein-cholesterol (LDL-C); we investigated its effects on LDL-C lowering in patients with mixed hyperlipidemia.